James Intrater, a director at Cardio Diagnostics Holdings, Inc., has exercised stock options for 3,286 shares at a price of $1.90 per share. This transaction, reported in a recent SEC filing, underscores Intrater's ongoing commitment to the company and its future.
Background
Cardio Diagnostics Holdings, Inc. operates in the in vitro and in vivo diagnostic substances industry. The company is incorporated in Delaware and has its business address in Chicago, Illinois. It is publicly traded under the ticker symbol CDIO. Cardio Diagnostics has undergone significant changes, including a name change from Mana Capital Acquisition Corp. in June 2021.
What the Filing Says
The SEC filing, dated October 2, 2026, details the exercise of stock options by Intrater on September 30, 2026. The filing states, "Transaction Code: A" indicating an acquisition of shares. Following this transaction, Intrater owns a total of 16,607 shares in the company.
Impact
This exercise of stock options may influence investor perception of Cardio Diagnostics Holdings. Intrater's actions could signal confidence in the company's direction and performance. Stakeholders, including shareholders and potential investors, may view this as a positive indicator of the company's stability and growth potential.
What's Next
The filing does not say what happens next.